Related Experiment Video
Updated: Jul 24, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
[Severe aplastic anemia after BTN162b2 mRNA COVID-19 vaccination in a patient undergoing hemodialysis]
1Department of Hematology, Shin-Koga Hospital.
Abstract:
Although vaccination against coronavirus infection 2019 (COVID-19) has been found to be effective, reports of adverse reactions continue to appear. We report the development of severe aplastic anemia post BTN162b2 mRNA COVID-19 vaccination in patient undergoing dialysis. The pathogenesis and risk factors for post-vaccination aplastic anemia remain unclear. We must remain vigilant to aplastic anemia following COVID-19 vaccination. The risk of aplastic anemia should be identified, and management methods should be established.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Dialysis
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Hemodialysis III: Nursing Management

